Zacks Investment Research on MSN
Countdown to DexCom (DXCM) Q4 earnings: Wall Street forecasts for key metrics
Wall Street analysts forecast that DexCom (DXCM) will report quarterly earnings of $0.65 per share in its upcoming release, pointing to a year-over-year increase of 44.4%. It is anticipated that ...
Dexcom announced a new wave of AI-powered features designed to help users understand how food and daily habits affect their ...
DexCom recently reported preliminary fourth-quarter results showing year-over-year revenue growth in both U.S. and ...
Zacks Investment Research on MSN
DexCom (DXCM) reports next week: Wall Street expects earnings growth
Wall Street expects a year-over-year increase in earnings on higher revenues when DexCom (DXCM) reports results for the ...
Partnership will enable two-way data flow between Dexcom glucose biosensors and apps and Oura Ring and the Oura App, providing a first-of-its-kind metabolic health management experience Co-marketing ...
We recently published 10 Stocks Bleeding Early. DexCom, Inc. (NASDAQ:DXCM) is one of the worst-performing stocks on Monday. DexCom fell for a fifth straight day on Monday, shedding 3.82 percent to ...
Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something important about this glucose monitoring specialist? DexCom shares last closed ...
DexCom (NASDAQ:DXCM) stock saw a notable increase of 16% on Friday following the announcement of its Q1 earnings and a share buyback program. The company’s first-quarter sales hit $1.04 billion, ...
DexCom treats about 2.5 million patients, with tons of room for more. The company's Q2 guidance bombshell tanked the stock. Competition from an unexpected source raises long-term concerns worth ...
SAN DIEGO--(BUSINESS WIRE)--This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...
DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage. Despite several risks, it could deliver substantial returns in the long run.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results